R&D Views & Analysis | pharmaphorum

Views & Analysis

Are microtaggants the key to making medicines smarter?

Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of patients.

Digital

The future of clinical trials innovation

Now what? The future of clinical trials after the pandemic

Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted.

Views & Analysis

A line of UK One Pound Coins on top of UK Banknotes (?5, ?10, ?20)

Arecor heads for London Stock Exchange with drug reformulati...

Arecor Therapeutics is planning to float on the London stock market, to raise funding and awareness for its developmental portfolio of biologic drugs, which are based on already-marketed dr

Views & Analysis

Report calls for better work culture in UK research

Create a positive working culture for the UK’s researchers, or watch the country’s standing as an innovation leader crumble, says new report.

Videos

Health Innovators: Teresa Arroyo-Gallego, nQ Medical

In this episode of our Health Innovators series, Paul Tunnah is joined by Teresa Arroyo-Gallego, chief data scientist at artificial intelligence technology company nQ Medical.

Views & Analysis